Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal. Silva Miguel L, de Sá J, Pinheiro B, Acosta C Value Health. 2015 Nov; 18(7):A758. Epub 2015 Oct 20. PMID: 26534247. Abstract CommentRecommendBookmarkWatch